Rice Hall James & Associates, LLC Coherus Bio Sciences, Inc. Transaction History

Rice Hall James & Associates, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$12.68 - $17.79 $2.71 Million - $3.8 Million	-213,748 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$12.95 - $15.41 $893,446 - $1.06 Million	-68,992 Reduced 24.4%	213,748 $2.96 Million
Q1 2021 May 14, 2021	BUY	$14.42 - $21.39 $1.04 Million - $1.55 Million	72,245 Added 34.32%	282,740 $4.13 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $1.22 Million - $1.4 Million	-73,866 Reduced 25.98%	210,495 $3.66 Million
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $2.9 Million - $3.31 Million	-166,571 Reduced 36.94%	284,361 $5.22 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $808,137 - $1.07 Million	56,004 Added 14.18%	450,932 $8.05 Million
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $3.53 Million - $6.82 Million	-302,625 Reduced 43.38%	394,928 $6.41 Million
Q4 2019 Jan 29, 2020	SELL	$16.33 - $21.37 $132,828 - $173,823	-8,134 Reduced 1.15%	697,553 $12.6 Million
Q3 2019 Oct 30, 2019	BUY	$16.3 - $23.37 $11.5 Million - $16.5 Million	705,687 New	705,687 $14.3 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $84.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.